Abstract
Currently, the prediction of improvement of left ventricular (LV) ejection fraction
(EF) after revascularization in patients with ischemic cardiomyopathy relies only
on viable myocardium extent, whereas both the amount of viable and scar tissue may
be important. A model was developed, based on the amount of viable and nonviable myocardium,
to predict functional recovery. Viable and scarred myocardium was defined by dobutamine
stress echocardiography (DSE) in 108 consecutive patients. LVEF before and 9 to 12
months after revascularization was assessed by radionuclide ventriculography; an improvement
of ≥5% was considered significant. In the 1,089 dysfunctional segments (63%), DSE
elicited biphasic response in 216 segments (20%), sustained improvement in 205 (19%),
worsening in 43 (4%), and no change in 625 (57%). LVEF improved in 39 patients (36%).
Only the numbers of biphasic and scar segments were predictors of improvement or no
improvement of LVEF (odds ratio 1.5, 95% confidence interval 1.2 to 1.7, p <0.0001
for biphasic segments; odds ratio 0.8, 95% confidence interval 0.7 to 0.9, p <0.0005
for scarred segments). The sustained improvement and worsening pattern were not predictive
of improvement or no improvement. A regression function, based on the number of scar
and biphasic segments, showed that the likelihood of recovery was 85% in patients
with extensive biphasic tissue and no scars and 11% in patients with extensive scars
and no biphasic myocardium. Patients with a mixture of scar and biphasic tissue had
an intermediate likelihood of improvement (50%). In patients with ischemic cardiomyopathy
and a mixture of viable and nonviable tissue, both numbers of viable and nonviable
segments should be considered to accurately predict functional recovery after revascularization.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Chronic heart failure in the United States.Circulation. 1998; 97: 282-289
- The epidemiology of heart failure.J Am Coll Cardiol. 1993; 22: 6A-13A
- Hibernating myocardium.N Engl J Med. 1998; 339: 173-181
- A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction.N Engl J Med. 1985; 312: 1665-1671
- Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease.J Am Coll Cardiol. 1997; 30: 1693-1700
- Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy.Circulation. 1995; 92: 3436-3444
- Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability.Circulation. 1997; 96: 793-800
- Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction.J Am Coll Cardiol. 1998; 32: 912-920
- Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization.Circulation. 1994; 90: 2687-2694
- Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography.J Am Coll Cardiol. 1999; 34: 163-169
- Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization. Role of low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT.Circulation. 1995; 92: II37-II44
- Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium).Circulation. 1997; 96: 3205-3214
- Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty.Circulation. 1995; 91: 663-670
- Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease.J Am Coll Cardiol. 1998; 3: 1002-1010
- Serial changes in response of hibernating myocardium to inotropic stimulation after revascularization.J Am Coll Cardiol. 1997; 30: 1233-1240
- Contractile reserve of dysfunctional myocardium after revascularization.J Am Coll Cardiol. 1997; 30: 633-640
- Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.J Am Soc Echocardiogr. 1989; 2: 358-367
- Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery.Circulation. 1997; 95: 53-58
- Akinesis becoming dyskinesis during high-dose dobutamine stress echocardiography.Am J Cardiol. 1994; 73: 896-899
- Rank Correlation Methods. Charles Griffin, London1962
- The natural history of congestive heart failure, the Framingham Study.N Engl J Med. 1971; 285: 1441-1446
- Mechanism of chronic regional postischemic dysfunction in humans.Circulation. 1993; 87: 1513-1523
- Hibernating myocardium.Circulation. 1997; 96: 2920-2931
- Only hibernating myocardium invariably shows early recovery after coronary revascularization.Circulation. 1996; 94: 308-315
- Head-to-head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease.Eur Heart J. 2000; 21: 981-991
Article info
Publication history
Accepted:
March 14,
2003
Received in revised form:
March 14,
2003
Received:
December 27,
2002
Identification
Copyright
© 2003 Excerpta Medica Inc. Published by Elsevier Inc. All rights reserved.
